BNM-III-170
BNM-III-170 is able to inhibit HIV-1 viral entry into target cells.
Product Specifications
CAS Number
[1859189-55-1]
UNSPSC
12352005
Target
HIV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/bnm-iii-170.html
Solubility
10 mM in DMSO
Smiles
O=C(NC1=CC=C(Cl)C(F)=C1)C(N[C@@H]2[C@@H](CNC(N)=N)CC3=C2C=CC(CNC)=C3)=O.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
Molecular Formula
C25H26ClF7N6O6
Molecular Weight
674.95
References & Citations
[1]Fritschi CJ, et al. Identification of gp120 Residue His105 as a Novel Target for HIV-1 Neutralization by Small-Molecule CD4-Mimics. ACS Med Chem Lett. 2021 Oct 29;12 (11) :1824-1831.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HIV-1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1170493-01 0.02 mg (E-Coli)
Recombinant Lactobacillus brevis D-ribose pyranase (rbsD)
Ask
View Details 
MBS1170493-02 0.1 mg (E-Coli)
Recombinant Lactobacillus brevis D-ribose pyranase (rbsD)
Ask
View Details MBS1170493-03 0.02 mg (Yeast)
Recombinant Lactobacillus brevis D-ribose pyranase (rbsD)
Ask
View Details MBS1170493-04 0.1 mg (Yeast)
Recombinant Lactobacillus brevis D-ribose pyranase (rbsD)
Ask
View Details 
MBS1170493-05 0.02 mg (Baculovirus)
Recombinant Lactobacillus brevis D-ribose pyranase (rbsD)
Ask
View Details